Filing Details

Accession Number:
0001127602-13-018632
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-29 16:32:33
Reporting Period:
2013-05-28
Filing Date:
2013-05-29
Accepted Time:
2013-05-29 16:32:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1436649 L Heather Cohen C/O Conmed Corporation
525 French Road
Utica NY 13502
Vp Corp Hr&Deputy Gen Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-28 2,000 $26.69 5,687 No 4 M Direct
Common Stock Disposition 2013-05-28 1,726 $34.04 3,961 No 4 F Direct
Common Stock Acquisiton 2013-05-28 2,000 $19.26 5,961 No 4 M Direct
Common Stock Disposition 2013-05-28 1,447 $34.04 4,514 No 4 F Direct
Common Stock Disposition 2013-05-28 2,522 $34.46 1,992 No 4 S Direct
Common Stock Disposition 2013-05-28 1,165 $34.62 827 No 4 S Direct
Common Stock Disposition 2013-05-29 827 $33.44 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Sars (Stock Appreciation Rights) Disposition 2013-05-28 2,000 $0.00 2,000 $26.69
Common Stock Sars (Stock Appreciation Rights) Disposition 2013-05-28 2,000 $0.00 2,000 $19.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
500 2018-06-01 No 4 M Direct
6,000 2020-06-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.18 to $34.58. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.60 to $34.72. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.36 to $33.51. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
  4. The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period.
  5. The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.